Posted by Thomas Dobrow on May 7th, 2024
StockNews.com cut shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a research report report published on Monday morning.
Separately, Cantor Fitzgerald reiterated an overweight rating and issued...
More of this article »